The Weekly Roundup: May 22-26

Expanding Ethnic Hair Care

In this month’s Cosmetic Conundrums column, Zoe Diana Draelos, MD, discusses solutions for ethnic and Afro-textured hair care.

Clinical Response Correlates With Serum Infliximab in Hidradenitis Suppurativa

A recent study supports a degree of correlation between trough serum concentration of infliximab and clinical response to infliximab in patients with the condition.

Skin Morbidities May Be Preventable Through Insulin Resistance, Obesity Treatment

Researchers analyzed dermatoses associated with obesity and insulin resistance in pediatric patients.

Giving Back With Skin Screenings

Renata Block, MMS, PA-C, spearheaded a skin cancer screening event for veterans in her hometown.

Metabolic Inflammation Contributes to Depression in Psoriatic Disease

As many as 1 in 5 patients with psoriasis experience depression as a comorbidity.

First Patient Dosed in Clinical Trial Combatting Pruritus

Topline results for the topical sodium channel blocker are expected in 2024.

FDA Approves Cyltezo Autoinjector Pen

The adalimumab biosimilar will be commercially available in the US starting July 1, 2023.

Orlucent Skin Fluorescence Imaging System Receives FDA Breakthrough Device Designation

The first-of-a-kind product uses a topically applied small peptide fluorescent dye and handheld imager to non-invasively detect a biomarker of early tissue changes.

Frontline Forum Part 3: Solutions in the Management and Treatment of Basal Cell Carcinoma

In part 3 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.

IncRNA Combination Promotes Psoriasis Formation

New research into the disease’s pathogenesis may inform future treatment options.

Anti-Sebum Cream Efficacious in Sebum Reduction, Improved Skin Hydration

Cream containing epigallocatechin gallate (EGCG) or EGCG combined with L-carnitine yielded a greater anti-sebum effect.

Recap From the Music City Symposium for Cosmetic Advances & Laser Education

If you weren’t able to attend SCALE 2023 or want to review the latest data, our full recap has you covered.

Pointers With Portela: How to Treat Tinea Versicolor

In this week’s Pointers with Portela, the 208SkinDoc gives his best product recommendations for Mother's Day gifts.

An Overview of Acral Peeling Skin Syndrome

The autosomal recessive disorder is primarily caused by mutations in the TGM5 gene and less frequently in the CSTA gene.

Telehealth Exercise Interventions Feasible, Safe for Those With Advanced Melanoma

While receiving checkpoint inhibitor therapy, patients with advanced melanoma benefitted from a telehealth exercise program.

POLL: What Type of Sunscreen Do You Recommend to Your Patients?

Click here to answer this week's poll.

Brepocitinib More Efficacious Than Placebo in Long-Term Psoriatic Arthritis Care

The JAK inhibitor demonstrated promising efficacy and safety.

FDA Approves Yuflyma, the Ninth Adalimumab Biosimilar

Yuflyma will be available to US patients in July 2023.

Best Practices for Identifying and Managing Granulomatous Dermatitis

The clinical and histologic subtypes encompassed by granulomatous dermatitis include palisaded neutrophilic granulomatous dermatitis and interstitial granulomatous dermatitis. This review compares the features of each cutaneous eruption.

The Mainstream Patient: May 26

This week's edition of the Mainstream Patient features stories about facial balancing, eyelid surgery 101, dermatologist-recommended sunscreen sticks, and more.

Dealing With Student Loan Debt: How to Budget for Repayment and Other Financial Goals

In this month’s Finance & Practice Management column, we illustrate the importance of developing and maintaining a budget for physicians at all stages of their careers.

Regions at Risk of Sunscreen Chemical Pollution Rely on Cautious SPF-Wearers

Coastal regions require environmentally-protective sun protection measures and best practices.

VEGF-A Inhibition Downregulates Blood Vessel Area in Psoriasis

In patients with high levels of VEGF-A and more severe psoriasis, downregulation of blood vessel area is more abrupt.